Cost-Effectiveness of Eplerenone in NYHA Class II Chronic Heart Failure Patients With Reduced LVEF: An Analysis for Greece

ClinicoEconomics and Outcomes Research - New Zealand
doi 10.2147/ceor.s107831
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Eplerenone, an Aldosterone Antagonist, Reduces Hospitalization and Death in Heart Failure Patients With Nyha Class II and an Ejection Fraction of Less Than 30%

Internal and Emergency Medicine
Internal MedicineEmergency Medicine
2011English

Pcv71 - Cost-Effectiveness of Sacubitril/Valsartan for the Treatment of Symptomatic Chronic Heart Failure With Reduced Ejection Fraction in Portugal

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Decision Rule for Stratification of Patients With Chronic Heart Failure of Functional Class II and III

Bulletin of Siberian Medicine
Molecular Medicine
2020English

Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients With Hyperkalemia

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2018English

The Cost-Effectiveness of Treatment for Chronic Heart Failure: A Systematic Review

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Cost-Effectiveness of Supervised Exercise Therapy in Heart Failure Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Canagliflozin for Japanese Patients With Chronic Heart Failure and Type II Diabetes

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2019English

Canaglioflozin for Japanese Patients With Chronic Heart Failure and Type II Diabetes

Journal of Nihon University Medical Association
2019English

Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction: Cost and Effectiveness in the Italian Context

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy